♟️ Monday 11 August 2025 Mon, 11 Aug 2025

CAR Group Limited reported a strong FY25 with revenue up 8% to $1.18 billion and net profit after tax rising 12% to $293 million, while announcing a leadership transition as CEO Cameron McIntyre steps down.

Invex Therapeutics reports a significantly reduced net loss for FY25, driven by lower R&D costs after closing its Phase III trial, while advancing promising pre-clinical Alzheimer’s research through a collaboration with Tessara Therapeutics.

ResMed Inc. reported a robust 10% increase in revenue to $5.15 billion for fiscal 2025, driven by strong demand in sleep and breathing health devices and residential care software. The company also expanded its diagnostic capabilities with the acquisition of VirtuOx, positioning itself for further growth in home-based health solutions.

Metro Performance Glass is set to strengthen its balance sheet and support its turnaround strategy through a $15 million to $24 million equity raise, with Amari Metals Australia poised to become the majority shareholder. This recapitalisation aims to reduce debt and improve operational focus amid challenging market conditions.

Metro Performance Glass proposes a $15–24 million recapitalisation involving a discounted rights offer and a major placement to Amari Metals, who would become the controlling shareholder.